Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc

$ 11.91 0 (0%) 10:08 PM EST
On watch
P/E:
12.54
P/B:
3.09
Market Cap:
$ 1.83B
Enterprise V:
$ 1.67B
Volume:
1.36M
Avg Vol (2M):
1.87M
Also Trade In:
Volume:
1.36M
Market Cap $:
1.83B
PE Ratio:
12.54
Avg Vol (2-Month):
1.87M
Enterprise Value $:
1.67B
PB Ratio:
3.09

Business Description

Description
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Name Current Vs Industry Vs History
Cash-To-Debt 1.38
Equity-to-Asset 0.57
Debt-to-Equity 0.7
Debt-to-EBITDA 1.72
Interest Coverage 17.28
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.38
Distress
Grey
Safe
Beneish M-Score -2.75
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.94
9-Day RSI 56.98
14-Day RSI 58.7
6-1 Month Momentum % -2.73
12-1 Month Momentum % 2.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 25.78
Quick Ratio 25.78
Cash Ratio 21.17
Days Sales Outstanding 93.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.6